CLYM

CLIMB BIO INC

CLYM·28658R106·US·Common Stock·Healthcare - Biotechnology-Activist

CLYM (CLIMB BIO INC) is held by 73 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($147.4M), FMR LLC ($88.5M), UBS Group AG ($44.4M). Net institutional sentiment: Bullish.

73
Holders
(4 Elite)
$536.5M
Total Value
73% (77)
Consensus
56 buying - 21 selling
13F: Insider & Congress: Updated regularly
CLYM

Smart Money Verdict

View all
Loading verdict
Held by 73 funds
4 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Feb 27, 2026 · Activists Aug 14, 2026 · Congress none

ActivistMBMPM BioImpact LLC0.0%Aug 14, 2026
ActivistFMR LLCFMR LLC11.9%Jul 8, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.33.0%Jul 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
11.3M$147.4M1.3%+41.76%
0
Increased
6.8M(+1060x)$88.5M0.0%+23.42%
48
Increased
3.4M(+3861.7%)$44.4M0.0%+25.80%
47
New
2.5M$32.7M0.0%+23.31%
40
Increased
2.4M(+486.3%)$30.7M0.0%+44.10%
47
New
1.9M$25.3M0.2%+23.31%
47
Increased
1.7M(+44.1%)$22.2M0.0%+80.44%
38
New
1.6M$20.6M0.1%+23.31%
39
Increased
1.3M(+275.5%)$16.9M0.0%+47.63%
46
Decreased
908,198(-28.8%)$11.8M0.0%+181.07%
0
Increased
790,000(+31.5%)$10.3M0.1%+159.93%
35
Increased
782,199(+149.9%)$10.2M0.0%+56.40%
45
Increased
686,772(+420.3%)$9M0.0%+41.08%
44
New
657,971$8.6M0.0%+23.31%
38
New
373,445$4.9M0.0%+23.31%
37
Increased
365,088(+55.9%)$4.8M0.0%+107.75%
38
Increased
330,290(+158.2%)$4.3M0.0%+62.09%
43
Increased
267,102(+6.8%)$3.5M0.0%+223.80%
28
Increased
266,649(+155.9%)$3.5M0.0%+61.54%
43
New
239,657$3.1M0.0%+23.31%
37

Showing 1-20 of 82

1 / 5
CLYMCLYMCLIMB BIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used